Announce Date | 12/31/1969 |
EPS Normalized Actual | $ In Line |
EPS GAAP Actual | $ In Line |
Revenue Actual | $0.000917222B |
Revenue Surprise | Beat by $0.917222M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 6.99 | 5.44859 | 0.000917222B | 100% | 0.92M |
FQ3 2024 (Sep 2024) | -1.8 | -3.14259 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -1 | -2.34259 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.78 | -2.35645 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | 0 | -2.08841 | 0B | -INF% | 0M |
FQ3 2021 (Sep 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ1 2022 (Mar 2022) | -0.13 | -0.13 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
5
EPS # of in-lines
2
Revenue # of Beats
1
Revenue # of Misses
0
Revenue # of in-lines
7
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.54141 | 6.99 | 5.44859 | 77.95% |
FQ3 2024 (Sep 2024) | 1.34259 | -1.8 | -3.14259 | 174.59% |
FQ2 2024 (Jun 2024) | 1.34259 | -1 | -2.34259 | 234.26% |
FQ1 2024 (Mar 2024) | 1.57645 | -0.78 | -2.35645 | 302.11% |
FQ4 2023 (Dec 2023) | 2.08841 | 0 | -2.08841 | -INF% |
FQ3 2021 (Sep 2021) | 0 | 0 | NAN% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ1 2022 (Mar 2022) | -0.13 | -0.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0B | $0.92M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |